What does PHARMASIMPLE do?

PHARMASIMPLE is a shop in Seneffe. Public Limited, started on 27 April 2012, 1 establishment.

What is the address of PHARMASIMPLE?

The registered office of PHARMASIMPLE is located at Rue Adolphe Quételet sn, 7180 Seneffe.

Is PHARMASIMPLE still active?

No. The CBE lists PHARMASIMPLE with legal situation “Opening faillissement”. The date of the court ruling is published in the Belgian Official Gazette; the register does not carry it.

Is PHARMASIMPLE registered on Peppol?

No, PHARMASIMPLE is currently not registered on the Peppol network.

What is the enterprise number of PHARMASIMPLE?

The enterprise number of PHARMASIMPLE is BE0845603735.

When was PHARMASIMPLE founded?

PHARMASIMPLE was founded on 27 April 2012.

Who are the directors of PHARMASIMPLE?

According to the 2021 annual accounts, the directors of PHARMASIMPLE are: MG CONSULTING, HAROLD LANNOY, DIDIER PETRE, MICHAEL WILLEMS, AM CONSULTANCY SPRL, SAMANDA SA.

Is PHARMASIMPLE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Opening faillissement according to the CBE, started on 27 April 2012; 1 annual account filed (fiscal year 2021); 6 directors known from the annual account.

How much profit did PHARMASIMPLE make in 2021?

PHARMASIMPLE recorded a loss after taxes of € 8,936,500 in financial year 2021.

What is the revenue of PHARMASIMPLE?

In its most recent annual accounts (2021), PHARMASIMPLE reported revenue of € 29,895,358.

How much does an employee at PHARMASIMPLE earn?

The average wage cost per full-time employee at PHARMASIMPLE was € 57,900 in 2021: staff costs of € 3.4 million for 57.9 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMASIMPLE have?

According to the 2021 annual accounts, PHARMASIMPLE has 57.9 full-time equivalents (FTE).

PHARMASIMPLE (Public Limited) - Seneffe - BE0845603735

Dossier PHARMASIMPLE, printed on 22 September 2026 from databakkes.be/en/0845603735/pharmasimple. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Legal situation KBO

Opening faillissement according to the CBE.

Financials

Financial year 2021

PHARMASIMPLE from Seneffe, company number BE0845603735, closed financial year 2021 with a result of € -8.9 million after tax. For that financial year PHARMASIMPLE recorded revenue of € 29.9 million and equity of € 4.1 million. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 2, 2022.

What it is worth Healthy

€ 4.1 million

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -8.9 million

Profit after tax over the fiscal year.

Cash in the bank

€ 1.1 million

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -11.1 million.

People and assets in 2021

Full-time equivalents

57.9

Average over the fiscal year, from the social balance sheet.

Wage cost Staff costs are payroll only. Director pay sits with services and miscellaneous goods: € 6 million in 2021, together with rent, insurance, accountants and other services. The accounts do not split that further.

€ 3.4 million

€ 57,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 42,475

Of which on lease € 16,352.

Debts at end 2021

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 9 million

€ 1.1 million is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 3.9 million

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 44 days on average.

Taxes and wages

€ 313,469

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

What happened to PHARMASIMPLE?

What happened at PHARMASIMPLE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

PHARMASIMPLE is active according to the CBE. Legal situation: Opening faillissement.

2026 AM CONSULTANCY SPRL stepped down as director. NBB
2025 HAROLD LANNOY stepped down as director. NBB
2025 DIDIER PETRE stepped down as director. NBB
2024 MICHAEL WILLEMS stepped down as director. NBB
Jun 2, 2022 New annual accounts for financial year 2021: loss of € 8.9 million. Source: NBB ↗
2021 MG CONSULTING stepped down as director. NBB
2021 HAROLD LANNOY became a director. NBB
2021 DIDIER PETRE became a director. NBB

In short

Paid € 1,416 in corporate taxes since 2021.

Pays suppliers within 44 days on average.

Original PDFs at the National Bank ↗

A new publication or filing at PHARMASIMPLE? We notify you, reason included.

Follow PHARMASIMPLE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

PHARMASIMPLE

PARA LCS 100%

ENOVA SANTE 100%

JUNIOR INVEST 12%

It owns 100% of PARA LCS, 100% of ENOVA SANTE and 12% of JUNIOR INVEST itself.

See the full network in the app

Directors

According to the 2021 annual accounts

MG CONSULTING

Director · represented by MARTIN GENOT

since 2020 · until 2021

HAROLD LANNOY

Director

since 2021 · until 2025

DIDIER PETRE

Director

Also active at: TMD CONSULTING

since 2021 · until 2025

MICHAEL WILLEMS

Director

· until 2024

AM CONSULTANCY SPRL

Director · represented by ANABELLE THIRY

Also active at: Pharmacy Cleaning

since 2021 · until 2026

SAMANDA SA

Director · represented by THIBAUT CLAES

Also active at: A.M.B., Floridienne, ORTIS, Barthel PAULS Fils - Barthel PAULS SOhne, RECYCLAGE ET VALORISATION TECHNIQUE, UPIGNAC, HOLZINDUSTRIE PAULS, ECOTERRES +40 more

since 2020 · until 2021

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Adolphe Quételet sn

7180 Seneffe

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0845.603.735

VAT number

BE 0845.603.735

Registered office

Rue Adolphe Quételet sn, 7180 Seneffe

Names & denominations

PHARMASIMPLE

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Opening faillissement

Start date

27 April 2012

Peppol

Not registered

Contact

0496397757

Activities · NACE

Overige niet-gespecialiseerde detailhandel

Detailhandel via postorderbedrijven of via internet

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMASIMPLE

Warning lights

Financials

What happened to PHARMASIMPLE?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions